Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biogen Idec (NQ:BIIB)

132.65 -3.71 (-2.72%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biogen Idec

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
53 54 Next >
Why Reata Pharmaceuticals Shares Are Falling Monday?
According to various reports, the FDA's neuroscience expert Billy Dunn is leaving the agency after more than 15 years, effective immediately. 
Via Benzinga
Week In Review: Keymed/Lepu Sign $1.2 Billion Deal Out-Licensing Claudin 18.2 ADC To AstraZeneca
Keymed Bio and Lepu Biopharma out-licensed global rights for their antibody drug conjugate to AstraZeneca in a deal that includes $63 million upfront. Meanwhile, the $937 million agreement between... 
Via Talk Markets
3 More Mid-Cap Biotechs The Street Sees Doubling
According to Wall Street research groups, these three mid-cap biotechs have 2x potential. It’s for the investor to decide if the upside justifies the risk. 
Via MarketBeat
Analyst Initiates Coverage of GE Healthcare, Says' Path To Greatness Well-Paved'
 
Via Benzinga
Biogen (BIIB) Q4 2022 Earnings Call Transcript
BIIB earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Why Biogen Stock Is Falling Today
 
Via Benzinga
Biogen Inches Higher On Quarterly Beat, Guides To 'Modest' Alzheimer's Drug Sales
The company expects "modest" Leqembi sales, but there's a caveat. 
Via Investor's Business Daily
2 Top Biotech Stocks Defying the Bear Market
These stocks soared in the double digits last year. 
Via The Motley Fool
Biogen Beats Q4 Earnings & Sales Estimates, Stock Up
Biogen reported fourth-quarter 2022 adjusted earnings per share (EPS) of $4.05. 
Via Talk Markets
Cisco, Analog Devices And 3 Stocks To Watch Heading Into Wednesday
With US futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
US Stocks Settle Mixed; Investor Optimism Improves
The CNN Money Fear and Greed index showed an improvement in the overall sentiment among US investors. 
Via Benzinga
Investors Are Awaiting The Name Of The New BoJ Governor
This week, the Japanese government will officially elect a new Governor of the Bank of Japan to replace Haruhiko Kuroda, whose decade at the Central Bank will end in April. 
Via Talk Markets
Q4 Reporting Season Pushes Past Halfway Mark: Coca-Cola, Cisco Systems, Palantir, Roku Lead Earnings This Week
The stock market pulled back in the week ended Feb. 10, dragged by some disappointing earnings and revised December inflation data. 
Via Benzinga
Is Biogen Stock a Buy Now?
Its new drug might succeed where the company faltered in 2021. 
Via The Motley Fool
Where Biogen Stands With Analysts
 
Via Benzinga
Why Anavex Life Sciences Stock Bolted Higher in January
The biotech's shares have been steadily leaking higher following positive late-stage Alzheimer's disease trial results. 
Via The Motley Fool
Sage Therapeutics-Biogen Partnered Depression Candidate Under Priority FDA Review, Analyst Says Its 'Incrementally Positive'
 
Via Benzinga
Sage Therapeutics and Biogen Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression
From Sage Therapeutics, Inc.
Via Business Wire
Biogen and Sage Therapeutics Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression
From Biogen Inc.
Via GlobeNewswire
FDA Rejects Eli Lilly's Donanemab For Alzheimer's Disease, Needs More Data
 
Via Benzinga
Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric
The company that remains still has a large pipeline of non-migraine assets. 
Via Investor's Business Daily
The 7 Most Undervalued Nasdaq Stocks to Buy in February 2023
For those seeking the best discounts in the tech-centered index, these are the most undervalued Nasdaq stocks to buy. 
Via InvestorPlace
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
The year has started well for biopharma companies on the regulatory front, as most decisions handed out during January were positive. The Food and Drug Administration has already cleared four new... 
Via Benzinga
7 CRISPR Stocks With the Best Long-Term Potential
CRISPR stocks are becoming commercially viable leading to substantial returns in 2023 and beyond, as the technology will only improve. 
Via InvestorPlace
Cassava Sciences Stock Undervalued with Its $124 Price Target?
Casava Sciences Inc (NASDAQ: SAVA) stock has been the topic of much controversy in its quest for FDA approval for its simufilam drug. The Company is a 
Via MarketBeat
Lecanemab Receives Priority Review Status in Japan
From Biogen Inc.
Via GlobeNewswire
Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer’s Disease Accepted by European Medicines Agency
From Biogen Inc.
Via GlobeNewswire
Is Biogen Stock a No-Brainer Buy After Eli Lilly's Alzheimer's Disease Setback?
Lilly's FDA rejection puts Biogen and its partner Eisai in the driver's seat in the Alzheimer's disease drug market. 
Via The Motley Fool
In A Stunner, Eli Lilly Stock Falls After FDA Delivers A Blow To Its Alzheimer's Drug
The company will need to complete its confirmatory study before asking for approval. 
Via Investor's Business Daily
Tech Stocks Get Netflix Boost Amid Jittery Wider Market On Friday, Dow Stares At 4th Straight Loss
U.S. stocks look set for a positive start on Friday, reversing course from the sell-off seen in the past three sessions. What Happened: Traders may have to contend with Fed speeches and housing market... 
Via Benzinga
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
53 54 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.